Skip to content

Public FDA record

Z-2690-2024: Vivo 45 LS, pressure and volume ventilator capable of delivering continuous or intermittent ventilatory s

Recall record Z-2690-2024 for Breas Medical, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2690-2024
Company in FDA record
Breas Medical, Inc.
FDA classification date
Sep 3, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class I

Reason stated in the source

There is a potential for short term (<7 days) elevated levels of formaldehyde emitted from the device into the patient breathing airpath in specific conditions.

Source facts

Action
On August 5, 2024, URGENT MEDICAL DEVICE CORRECTION letters were sent to consignees. Actions to be taken by Customer / User: 1. Since the elevated levels of formaldehyde were observed with the Vivo 45 LS operated at higher room temperatures, 40C (104F), as a matter of precaution, Breas Medical is lowering the maximum room air temperature for operation of the device from 40C (104F) to 30C (86F). 2. The following additional measure applies to new Vivo 45 LS devices distributed on or before July 24, 2024, that have not been in use for at least 14 days: Pre-run the device for at least 14 days in an ambient room temperature of at least 20C (68F). The pre-run can be performed in any ventilation treatment mode (for example: CPAP at 4 cmH2O). Make sure that the device s air outlet is not blocked, so that the air flows out from the device. Devices being pre-run should be in a dedicated, well-ventilated room. Personnel working with the devices should be in the room only intermittently, for time needed to connect and setup or disconnect devices. 3. Please ensure all potential users in your facility are made aware of this safety notification and the recommended actions. 4. Retain this document as an addendum to the Instructions for Use and for your records. Please keep a copy of this document available with the Instructions for Use. 5. Complete and return the attached acknowledgement form to vivotechnicalsupport@breas.com and inga.dolezar@breas.com (You only need to send one acknowledgement form.) Contact Information: If you have any questions or concerns regarding this notification, please contact Breas Medical Inc. service or your local Service Representative. Breas Medical Inc. service can be reached at 855-436-8724 ext. 110 between 8.00am and 5.00pm ET Mondays through Fridays, or by e-mail vivotechnicalsupport@breas.com.
Initiated
2024-07-25
Root cause
Under Investigation by firm
Distribution
US Nationwide.
Recall number
Z-2690-2024
Recall status
Open, Classified
CDRH record ID
209193
FDA classified
2024-09-03
Recall event number
95042

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗